Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabozantinib maintenance in high-grade undifferentiated uterine sarcoma
2013-000762-11Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in uterine sarcoma comparing Cabozantinib maintenance with Placebo maintenance (2 arms). Primary endpoint: Progression-free survival rate. Started Jun 2014; status: completed.
02
Drugs
cabozantinib
03
Conditions
uterine sarcoma
Beyond the preview
Go deeper on 2013-000762-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000762-11.